Author + information
- Received December 7, 2007
- Revision received January 15, 2008
- Accepted January 24, 2008
- Published online June 3, 2008.
- Vasilis C. Babaliaros, MD⁎ (, )
- Jacob T. Green, MD,
- Stamatios Lerakis, MD, FACC,
- Michael Lloyd, MD and
- Peter C. Block, MD, FACC
- ↵⁎Reprint requests and correspondence:
Dr. Vasilis Babaliaros, Department of Cardiology, Emory University Hospital, 1364 Clifton Road, Suite F606, Atlanta, Georgia 30322.
Transseptal (TS) catheterization was introduced in 1959 as a strategy to directly measure left atrial (LA) pressure. Despite acceptable feasibility and safety, TS catheterization has been replaced by indirect measurements of LA pressure using the Swan-Ganz catheter. Today, TS puncture is rarely performed for diagnostic purposes but continues to be performed for procedures such as balloon mitral valvuloplasty, antegrade balloon aortic valvuloplasty, and ablation of arrhythmias in the LA. Thus, the “art” of TS puncture has been lost, except in centers that perform these procedures with regularity. Recently, there has been a renewed interest in the TS technique because of emerging therapeutic procedures for structural heart disease and atrial fibrillation ablation. Invasive cardiologists will have to refamiliarize themselves with the TS technique, newer TS devices, and advanced ultrasound imaging for guidance of the procedure.
Dr. Babaliaros is a consultant for Medtronic. Dr. Block is an E-Valve consultant and stock holder, Direct Flow stock holder, Medtronic consultant, and Ample Medical consultant. Dr. Lloyd is a Medtronic research grant recipient.
- Received December 7, 2007.
- Revision received January 15, 2008.
- Accepted January 24, 2008.
- American College of Cardiology Foundation